| LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade R Shen, MA Postow, M Adamow, A Arora, M Hannum, C Maher, P Wong, ... Science translational medicine 13 (608), eabf5107, 2021 | 59 | 2021 |
| Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma JS Holm, SA Funt, A Borch, KK Munk, AM Bjerregaard, JL Reading, ... Nature Communications 13 (1), 1935, 2022 | 46 | 2022 |
| Deciphering radiological stable disease to immune checkpoint inhibitors J Luo, S Wu, H Rizvi, Q Zhang, JV Egger, JC Osorio, AJ Schoenfeld, ... Annals of Oncology 33 (8), 824-835, 2022 | 25 | 2022 |
| Circadian rhythm variations and nutrition in children M Gombert, J Carrasco-Luna, G Pin-Arboledas, P Codoñer-Franch Journal of Child Science 8 (01), e60-e66, 2018 | 10 | 2018 |
| Checkpoint blockade in melanoma patients with underlying chronic lymphocytic leukemia JW Smithy, MJ Pianko, C Maher, MA Postow, AN Shoushtari, P Momtaz, ... Journal of Immunotherapy 44 (1), 9-15, 2021 | 9 | 2021 |
| Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring AJ Widman, M Shah, N Øgaard, CC Khamnei, A Frydendahl, ... bioRxiv, 2022.01. 17.476508, 2022 | 8 | 2022 |
| Durable clinical benefit from combination ipilimumab (IPI) and nivolumab (NIVO) in anti-PD-1 therapy resistant, platinum resistant metastatic urothelial carcinoma (mUC). NM Keegan, SA Funt, BE Kania, G Iyer, JM Clement, AS McCoy, G Hettich, ... Journal of Clinical Oncology 37 (7_suppl), 481-481, 2019 | 4 | 2019 |
| Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade. B Santomasso, A Haggiagi, R Malani, CA Maher, JN Holder, Y Shames, ... Journal of Clinical Oncology 36 (15_suppl), 3084-3084, 2018 | 4 | 2018 |
| Integration of peripheral blood‐and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma RS Vanguri, JW Smithy, Y Li, M Zhuang, CA Maher, N Aleynick, X Peng, ... The Journal of Pathology 261 (3), 349-360, 2023 | 2 | 2023 |
| Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced … JW Smithy, HL Kalvin, V Raber, CA Maher, J Kleman, DAG McIntyre, ... Journal of Clinical Oncology 41 (16_suppl), 9517-9517, 2023 | 2 | 2023 |
| Interrogation of neoantigen-specific CD8 T cells in peripheral blood following PD-L1 blockade in patients with metastatic urothelial carcinoma (mUC). JS Holm, SA Funt, AM Bjerregaard, JL Reading, CA Maher, AM Regazzi, ... Journal of Clinical Oncology 38 (15_suppl), 3075-3075, 2020 | 1 | 2020 |
| 1303 Spatial topic modeling of tumor microenvironment with multiplexed imaging X Peng, JW Smithy, N Aleynick, M Zhuang, Y Li, J Lee, AP Moy, C Maher, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 135 Integration of T-cell activation and tumor mutation burden predicts anti-PD-1 response F Ehrich, M Adamow, C Maher, J Lee, X Peng, JW Smithy, SA Funt, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma JW Smithy, X Peng, AP Moy, N Aleynick, M Zhuang, Y Li, C Maher, J Lee, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 128 staRgate: a flexible density-based automated gating pipeline for complex high-dimensional flow cytometry data J Lee, M Adamow, C Maher, X Peng, P Wong, F Ehrich, MK Callahan, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| A topic modeling approach reveals the dynamic T cell composition of peripheral blood during cancer immunotherapy X Peng, J Lee, M Adamow, C Maher, MA Postow, MK Callahan, ... Cell Reports Methods 3 (8), 2023 | | 2023 |
| Uncovering the hidden structure of dynamic T cell composition in peripheral blood during cancer immunotherapy: a topic modeling approach X Peng, J Lee, M Adamow, C Maher, MA Postow, MK Callahan, ... bioRxiv, 2023 | | 2023 |
| 1297 Uncovering the hidden structure of T cell compositions in peripheral blood after immune checkpoint inhibitor X Peng, J Lee, M Adamow, C Maher, M Callahan, K Panageas, R Shen Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
